[go: up one dir, main page]

ZA200702643B - Bissulfonamide compounds as agonists of GalR1, compositions, and methods of use - Google Patents

Bissulfonamide compounds as agonists of GalR1, compositions, and methods of use

Info

Publication number
ZA200702643B
ZA200702643B ZA200702643A ZA200702643A ZA200702643B ZA 200702643 B ZA200702643 B ZA 200702643B ZA 200702643 A ZA200702643 A ZA 200702643A ZA 200702643 A ZA200702643 A ZA 200702643A ZA 200702643 B ZA200702643 B ZA 200702643B
Authority
ZA
South Africa
Prior art keywords
bissulfonamide
galr1
agonists
compositions
compounds
Prior art date
Application number
ZA200702643A
Inventor
Adnan M M Mjalli
Gaddam Bapu
Rao Mohan
Bondlela Muralidhar
Gopalaswamy Ramesch
Robert C Andrews
Davis Stephen
Simila Suivi
Ren Tan
Original Assignee
Transtech Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transtech Pharma Inc filed Critical Transtech Pharma Inc
Publication of ZA200702643B publication Critical patent/ZA200702643B/en

Links

ZA200702643A 2004-10-21 2005-10-20 Bissulfonamide compounds as agonists of GalR1, compositions, and methods of use ZA200702643B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62069904P 2004-10-21 2004-10-21

Publications (1)

Publication Number Publication Date
ZA200702643B true ZA200702643B (en) 2008-08-27

Family

ID=38880904

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200702643A ZA200702643B (en) 2004-10-21 2005-10-20 Bissulfonamide compounds as agonists of GalR1, compositions, and methods of use

Country Status (2)

Country Link
CN (1) CN101068804A (en)
ZA (1) ZA200702643B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6030568B2 (en) 2010-12-16 2016-11-24 アラーガン、インコーポレイテッドAllergan,Incorporated Novel 1,2-bis-sulfonamide derivatives as chemokine receptor modulators

Also Published As

Publication number Publication date
CN101068804A (en) 2007-11-07

Similar Documents

Publication Publication Date Title
IL176571A0 (en) Substituted azole derivatives, compositions, and methods of use
IL191137A0 (en) Polycation-polyanion complexes, compositions and methods of use thereof
PL2335782T3 (en) Use of compositions comprising HFCO-1233zd
IL183940A0 (en) Glp-1 agonists, compositions, methods and uses
IL222698A0 (en) Benzazole derivatives, compositions, and methods of use as b- secretase inhibitors
ZA200700351B (en) Compounds, compositions and methods
IL179595A0 (en) Substituted indazoles, compositions containing same, preparation and use
ZA200806842B (en) Imidazole-based compounds,compositions comprising them and methods of their use
EP1858513A4 (en) Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use
IL186179A0 (en) Composition containing antidementia agent
EP1954685A4 (en) Furoxan compounds, compositions and methods of use
EP1962852A4 (en) Compounds, compositions and methods
ZA200700809B (en) Corrosion-inhibiting compositions and use thereof
IL190477A0 (en) Pyrazole derivatives, compositions containing such compounds and methods of use
IL179530A0 (en) Novel compounds, pharmaceutical compositions containing same and methods of use for same
EP1765873A4 (en) Methods and compositions using cd3 agonists
ZA200804814B (en) Mortar composition, method of preparation thereof and use thereof
GB0819432D0 (en) Compound, composition and use
IL181991A0 (en) Bissulfonamide compounds as agonists of galr1, compositions, and methods of use
IL186606A0 (en) Compositions and uses of amooranin compounds
GB0412584D0 (en) Composition of matter
EP1797078A4 (en) Compounds, compositions containing them, preparation thereof and uses thereof iii
EP1727511A4 (en) Hair growth agent composition
GB0520930D0 (en) Composition and method of use
ZA200702643B (en) Bissulfonamide compounds as agonists of GalR1, compositions, and methods of use